Holen Sie sich die Stockscreener-App
12.77
0.39%
0.05
Handel nachbörslich:
12.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.72
Offen:
$12.65
24-Stunden-Volumen:
3.11M
Relative Volume:
0.84
Marktkapitalisierung:
$2.55B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-6.1691
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+5.98%
1M Leistung:
+10.85%
6M Leistung:
-20.34%
1J Leistung:
-34.88%
1-Tages-Spanne:
$12.57
$12.84
1-Wochen-Bereich:
$12.10
$13.03
52-Wochen-Spanne:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.77 | 2.54B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
525.04 | 187.46B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.40 | 57.96B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.87 | 39.68B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.31 | 37.32B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.50 | 37.29B | 5.26B | 1.44B | 1.76B | 9.7713 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Global Dental Market Forecast Report and Company Analysis - GlobeNewswire
All about Dentsply Sirona World Dubai 2026 - Dental Tribune US
Cooke & Bieler LP Decreases Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Options Flow: Is DENTSPLY SIRONA Inc stock good for income investors2025 Pullback Review & Weekly Top Performers Watchlists - baoquankhu1.vn
Investment Review: Is Adicet Bio Inc. attractive for institutional investorsOptions Play & Short-Term High Return Strategies - baoquankhu1.vn
The Truth About Dentsply Sirona Inc: Wall Street Sleeper or Next Big Health-Tech Play? - AD HOC NEWS
Lobbying Update: $20,000 of DENTSPLY SIRONA INC. lobbying was just disclosed - Quiver Quantitative
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Announces Target Price $13 - 富途资讯
Dental Market Dynamics and Contributions by Dentsply Sirona, - openPR.com
Dentsply Sirona (XRAY) Gains 4.4% After Mizuho Raises Price TargetNews and Statistics - IndexBox
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know - Finviz
Dental Market Overview and Leading Players: Dentsply Sirona, - openPR.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilent (A), DENTSPLY SIRONA (XRAY) and Exact Sciences (EXAS) - The Globe and Mail
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Campbell & CO Investment Adviser LLC - MarketBeat
Dentsply Can't Shed Investors' Aligner Injury Cover-Up Suit - Law360
Mizuho Analyst Steven Valiquette Raises Price Target for XRAY to $14.00 | XRAY Stock News - GuruFocus
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Dentsply Investors Advance Byte Teeth Aligner Injury Claims (3) - Bloomberg Law News
A Look At Dentsply Sirona (XRAY) Valuation After Renewed Patterson And Expanded Benco Distribution Deals - Sahm
Nordea Investment Management AB Purchases 142,451 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DS World Dubai opens with focus on connected dentistry - Dental Tribune US
Gains Recap: What is the dividend yield of DENTSPLY SIRONA IncQuarterly Profit Report & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
8.5% Yield From IG-Rated Dentsply Sirona Bonds Still Look Interesting (NASDAQ:XRAY) - Seeking Alpha
Dividend Watch: What is the dividend yield of DENTSPLY SIRONA IncJuly 2025 Final Week & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Dental Fillings Market Set to Surge: Innovative Materials and Digital Workflows Drive Growth at 8.65% CAGR - GlobeNewswire Inc.
Aug Shorts: Is DENTSPLY SIRONA Inc in a long term uptrendJuly 2025 Big Picture & Real-Time Buy Zone Alerts - baoquankhu1.vn
Is Dentsply Sirona (XRAY) Pricing Reflect Recent Slide In Dental Equipment Sentiment Accurately - Sahm
Halper Sadeh Investigates Dentsply Sirona Executives for Breach of Fiduciary Duties - Intellectia AI
Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights - FinancialContent
How Expanded U.S. Distribution And Board Changes At DENTSPLY SIRONA (XRAY) Have Changed Its Investment Story - Yahoo Finance
Market Outlook: Will CECO benefit from rate cutsQuarterly Profit Summary & Weekly Sector Rotation Insights - baoquankhu1.vn
Dentsply Sirona and Patterson Dental renew U.S. distribution agreement By Investing.com - Investing.com Nigeria
Patterson Dental Holdings and DENTSPLY SIRONA Inc. Renew U.S. Dental Technology Distribution Partnership - marketscreener.com
Dentsply Sirona and Patterson Dental renew U.S. distribution agreement - Investing.com
Dentsply Sirona IncCo And Patterson Dental Renew Distribution Agreement - TradingView
Dentsply Sirona Renews U.S. Dental Technology Distribution Deal With Patterson - Nasdaq
Dentsply Sirona Renews Patterson Dental Technology Distribution Deal - TipRanks
Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership - manilatimes.net
Dentsply Sirona Inc and Patterson Dental renew U.S. dental technology distribution agreementSEC filing - marketscreener.com
DENTSPLY SIRONA Inc Renews U.S. Distribution Agreement with Patterson Dental - TradingView — Track All Markets
XRAYDentsply Sirona Inc Latest Stock News & Market Updates - Stock Titan
Benco Dental to offer Dentsply Sirona’s full technology portfolio By Investing.com - Investing.com Nigeria
Dentsply Sirona appoints former Patterson CEO Don Zurbay to board By Investing.com - Investing.com Nigeria
DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 5.12% Dividend Yield Amidst Mixed Financial Signals - DirectorsTalk Interviews
Benco Dental to offer Dentsply Sirona’s full technology portfolio - Investing.com
Benco Dental Expands Partnership with Dentsply Sirona to Offer Comprehensive Dental Technology Solutions - Quiver Quantitative
Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions - The Manila Times
XRAY Forms Committee to Propel Return-To-Growth Strategy - GuruFocus
Dentsply Sirona Inc. Appoints Donald J. Zurbay to Board and Member of the Audit and Finance Committee , Effective January 10, 2026 - marketscreener.com
Dentsply Sirona appoints former Patterson CEO Don Zurbay to board - Investing.com
Dentsply Sirona appoints Donald Zurbay to board of directors - marketscreener.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):